ADI-001 demonstrated 75% CR and ORR rate across all dose levels with favorable safety and tolerability profile in patients with relapsed/refractory high grade aggressive NHL, as of May 31, 2022 data-cut date ADI-001 received FDA Fast Track Designation Strong balance sheet with $304.3 million in cash and cash equivalents, as adjusted for anticipated proceeds from … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Oncology Drugs Market (2022-2027) by Drug Class, Indication, End-user, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Oncology Drugs Market is estimated to be USD 156.49 Bn in 2022 and is expected to reach USD 224.35 Bn by 2027, growing … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmic Drug Delivery System Market 2021-2031 by Product, Dosage Form, Disease, Setting, and Region: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. The global ophthalmic drug delivery system market will reach $ 30,013.7 million by 2031, growing by 6.9% annually over 2021-2031, driven by the growing prevalence of … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Cancer Pain Market (2022-2027) by Type, Disease Indication, Application, and Geography, Competitive Analysis, Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Cancer Pain Market is estimated to be USD 8.14 Bn in 2022 and is projected to reach USD 10.45 Bn by 2027, growing at … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Pain Management Devices Market 2021-2031 by Product, Application, Mode of Purchase, and Region: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. The global pain management devices market will reach $9,971.6 million by 2031, growing by 8.3% annually over 2021-2031, driven by the growing demand for chronic pain management … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Mini Bioreactors and Micro Bioreactors Market, Distribution by Type of Cell Culture, Mode of Operation, End User and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035” report has been added to ResearchAndMarkets.com’s offering. The ‘Mini Bioreactors and Micro Bioreactors Market, 2022-2035’ report features an extensive study of the current landscape and the … [Read more…]
The first-of-its-kind, CRISPR-based therapeutic aims to stop the progression of Duchenne muscular dystrophy in a single-patient dosing BOSTON–(BUSINESS WIRE)–Cure Rare Disease (CRD) – a Boston-based 501c3 nonprofit biotech – announces the approval from the U.S. Food and Drug Administration (FDA) to administer its very first therapeutic. The drug, named CRD-TMH-001, treats muscle promoter and exon … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Needlestick Safety Injection Devices Market by Type of Device, Purpose of Device, Usability, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035” report has been added to ResearchAndMarkets.com’s offering. The “Needlestick Safety Injection Devices Market” report features an extensive study on the current market landscape, offering an informed opinion on … [Read more…]
– Just – Evotec Biologics will apply its fully integrated technology platform to develop an optimized commercial process for ALPN-303, a Dual BAFF/APRIL Inhibitor for Systemic Lupus Erythematosus and Other Autoimmune and Inflammatory Diseases – HAMBURG, Germany & SEATTLE–(BUSINESS WIRE)–Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and Alpine Immune Sciences, Inc. … [Read more…]
Mr. Nunn will add unparalleled pharmaceutical industry insights for Humanetics, which is advancing its lead drug candidate BIO 300 through clinical trials MINNEAPOLIS–(BUSINESS WIRE)–Humanetics Corporation (Humanetics), a clinical-stage specialty pharmaceutical company pioneering radiation countermeasures, adjunctive oncology therapies, and pulmonary protective therapies for COVID-19, has announced the addition of renowned venture capitalist and life science industry … [Read more…]
